REVERSIBILITY OF PURKINJE CELL PATHOLOGY AND ATAXIC BEHAVIOR IN A TETRACYCLINE-RESPONSIVE TRANSGENIC MODEL OF SPINOCEREBELLAR ATAXIA TYPE 1 (SCA1).

MLA

Zu, T., et al. “Reversibility of Purkinje Cell Pathology and Ataxic Behavior in a Tetracycline-Responsive Transgenic Model of Spinocerebellar Ataxia Type 1 (Sca1).” Journal of Neuropathology & Experimental Neurology, vol. 63, no. 5, May 2004, p. 555. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=113888244&authtype=sso&custid=ns315887.

APA

Zu, T., Orr, H. T., & Clark, H. B. (2004). Reversibility of Purkinje Cell Pathology and Ataxic Behavior in a Tetracycline-Responsive Transgenic Model of Spinocerebellar Ataxia Type 1 (Sca1). Journal of Neuropathology & Experimental Neurology, 63(5), 555.

Chicago

Zu, T, H T Orr, and H B Clark. 2004. “Reversibility of Purkinje Cell Pathology and Ataxic Behavior in a Tetracycline-Responsive Transgenic Model of Spinocerebellar Ataxia Type 1 (Sca1).” Journal of Neuropathology & Experimental Neurology 63 (5): 555. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=113888244&authtype=sso&custid=ns315887.